<DOC>
	<DOCNO>NCT00912002</DOCNO>
	<brief_summary>A single dose , open label study characterize route elimination determine mass balance MK-0941 . A single 40 mg dose MK-0941 give orally male participant type 2 diabetes . After drug administration , blood , urine , fecal sample collect determine relative quantity 14C-labeled MK-0941 .</brief_summary>
	<brief_title>A Study Absorption , Metabolism , Excretion Mass Balance After Single Dose Administration MK-0941 ( MK-0941-016 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<criteria>Subject diagnose type 2 diabetes , treat diet exercise oral antihyperglycemic agent Subject willing follow American Heart Association diet exercise program throughout study Subject nonsmoker and/or use nicotine product least 6 month Subject history stroke , seizure , major neurological disorder Subject history neoplastic disease Subject recently abnormal bowel habit , diarrhea , loose stool constipation Subject history type 1 diabetes mellitus Subject receive insulin within past 12 week Subject recent history eye infection Subject diagnose glaucoma blind Subject consume 3 alcoholic beverage per day Subject consume 6 serving coffee , tea , cola per day Subject major surgery , donate lose blood past 4 week Subject multiple severe allergy food drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>